The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
eureka therapeutics | 202 |
five prime therapeutics | 7 |
novartis | 5 |
bluebird bio | 3 |
eureka therapeutics | 86 |
five prime therapeutics | 4 |
bluebird bio | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
t cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2 | 36 | 2011 |
chimeric antigen receptors targeting fc receptor-like 5 and uses thereof | 16 | 2014 |
constructs targeting afp peptide/mhc complexes and uses thereof | 15 | 2015 |
antibodies targeting g-protein coupled receptor and methods of use | 15 | 2014 |
antibodies targeting b-cell maturation antigen and methods of use | 15 | 2014 |
chimeric antigen receptors targeting g-protein coupled receptor and uses thereof | 14 | 2014 |
chimeric antigen receptors targeting b-cell maturation antigen and uses thereof | 14 | 2014 |
antibody agents specific for human cd19 and uses thereof | 13 | 2015 |
antibody/t-cell receptor chimeric constructs and uses thereof | 13 | 2015 |
cell lines and proteins with variant glycosylation pattern | 13 | 2008 |